Atypical neuroleptic malignant syndrome: A systematic review of case reports

K Singhai, PP Kuppili, N Nebhinani - General hospital psychiatry, 2019 - Elsevier
Results A total of 20 cases had met the criteria for atypical NMS [[21],[22],[23],[24],[25],[26],[
27],[28],[29],[30],[31],[32],[33],[34],[35],[36],[37],[38],[39],[40],[41]]. Profile of cases and details …

[HTML][HTML] Treatment of movement disorder emergencies

SJ Frucht - Neurotherapeutics, 2014 - Elsevier
Movement disorder emergencies are defined as clinical scenarios where a movement
disorder develops over hours to days, and in which morbidity and even mortality can result …

Consensus paper of the WFSBP task force on biological markers: biological markers for alcoholism

E Hashimoto, PF Riederer… - The world journal of …, 2013 - Taylor & Francis
Objectives. This article presents an overview of the current literature on biological markers
for alcoholism, including markers associated with the pharmacological effects of alcohol and …

Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database

G Cicala, R de Filippis, MA Barbieri… - Frontiers in …, 2023 - frontiersin.org
Introduction Long-acting injectable antipsychotics (LAIs) have proven to be effective in the
maintenance treatment of patients suffering from schizophrenia, and their safety and …

[PDF][PDF] Revisiting amantadine as a treatment for drug-induced movement disorders

SN Caroff, R Jain, JF Morley - Ann Clin Psychiatry, 2020 - mhaus.org
BACKGROUND: Amantadine, an aliphatic primary amine with complex actions on
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …

Key Points in remote-controlled drug delivery: From the carrier design to clinical trials

DV Voronin, AA Abalymov, YI Svenskaya… - International Journal of …, 2021 - mdpi.com
The increased research activity aiming at improved delivery of pharmaceutical molecules
indicates the expansion of the field. An efficient therapeutic delivery approach is based on …

Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study

R Linertová, P Serrano-Aguilar, M Posada-de-la-Paz… - Health policy, 2012 - Elsevier
OBJECTIVES: The BURQOL-RD project is intended to develop a disease based model
capable of quantifying the socio-economic burden and health-related quality of life for …

Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database

T Anzai, K Takahashi… - Psychiatry and Clinical …, 2019 - Wiley Online Library
Aim This study evaluates reports on neuroleptic malignant syndrome (NMS) as an adverse
event associated with the use of atypical antipsychotic agents (AAA) in Japan. We examined …

[HTML][HTML] Neuroleptic malignant syndrome

EFM Wijdicks - UpToDate, Waltham, MA.(Accessed on May 30, 2014) …, 2014 - medilib.ir
INTRODUCTION—Neuroleptic malignant syndrome (NMS) is a life-threatening neurologic
emergency associated with the use of antipsychotic (neuroleptic) agents and characterized …

Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis

WM Sweileh - Orphanet Journal of Rare Diseases, 2024 - Springer
Objective This study aimed to analyze and map scientific literature on Neuroleptic Malignant
Syndrome (NMS) and Serotonin Syndrome (SS) from prestigious, internationally indexed …